How do you manage hematologic toxicities in solid tumor patients treated with immune checkpoint inhibitors?   

If these are presumed to be immune-mediated (e.g. immune neutropenia or immune thrombocytopenia), do you treat with steroids?



Answer from: Medical Oncologist at Academic Institution